Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cardiovascular Syst (CSII)

Cardiovascular Syst (CSII)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,450,155
  • Shares Outstanding, K 34,826
  • Annual Sales, $ 217,040 K
  • Annual Income, $ 1,710 K
  • 60-Month Beta 1.84
  • Price/Sales 6.78
  • Price/Cash Flow 249.23
  • Price/Book 10.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.04
  • Number of Estimates 5
  • High Estimate 0.05
  • Low Estimate 0.02
  • Prior Year 0.11
  • Growth Rate Est. (year over year) -63.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.49 +9.18%
on 06/03/19
45.61 -7.87%
on 06/18/19
+2.51 (+6.34%)
since 05/24/19
3-Month
32.02 +31.25%
on 04/22/19
45.61 -7.87%
on 06/18/19
+3.86 (+10.10%)
since 03/26/19
52-Week
24.84 +69.18%
on 12/24/18
45.61 -7.87%
on 06/18/19
+11.25 (+36.53%)
since 06/26/18

Most Recent Stories

More News
Here's Why You Should Hold on to Surmodics (SRDX) Stock Now

Surmodics (SRDX) is gaining from consistent growth In Vitro Diagnostics (IVD) unit and persistent efforts to boost R&D functionalities.

OXFD : 13.34 (-1.40%)
SRDX : 39.11 (-0.99%)
HAE : 115.88 (-0.62%)
CSII : 41.15 (-1.18%)
Here's Why You Should Hold on to McKesson (MCK) Stock Now

McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market.

OXFD : 13.34 (-1.40%)
MCK : 129.70 (-1.59%)
HAE : 115.88 (-0.62%)
CSII : 41.15 (-1.18%)
Here's Why You Should Retain Allscripts (MDRX) Stock Now

Allscripts (MDRX) is gaining steadily from strategic acquisitions and solid prospects in Sunrise EHR platform. However, integration risks remain a woe.

OXFD : 13.34 (-1.40%)
MDRX : 11.16 (-0.27%)
HAE : 115.88 (-0.62%)
CSII : 41.15 (-1.18%)
Here's Why You Should Retain NextGen Healthcare (NXGN) Stock

NextGen Healthcare (NXGN) is gaining traction from the U.S. RCM market and the growing EHR market. However, margin pressure remains a concern.

NXGN : 18.64 (-0.37%)
HAE : 115.88 (-0.62%)
QDEL : 56.96 (-3.11%)
CSII : 41.15 (-1.18%)
Here's Why You Should Hold on to Medidata (MDSO) Stock Now

Medidata Solutions (MDSO) continues to benefit from solid R&D focus, Rave Genomics platform and cloud-based services. However, stiff competition remains a concern.

MDSO : 90.35 (-0.39%)
HAE : 115.88 (-0.62%)
CSII : 41.15 (-1.18%)
QDEL : 56.96 (-3.11%)
Cardiovascular Systems (CSII) Up 6.4% Since Last Earnings Report: Can It Continue?

Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CSII : 41.15 (-1.18%)
Here's Why You Should Bet on Merit Medical (MMSI) Stock Now

Merit Medical (MMSI) continues to benefit from solid product pipeline, HeRO product line and persistent focus on R&D.

MMSI : 58.06 (-1.34%)
HAE : 115.88 (-0.62%)
CSII : 41.15 (-1.18%)
QDEL : 56.96 (-3.11%)
Here's Why You Should Consider Betting On CONMED Stock Now

CONMED (CNMD) continues to benefit from robust international sales, broad product portfolio and continued focus on R&D.

HAE : 115.88 (-0.62%)
CNMD : 84.28 (-0.94%)
CSII : 41.15 (-1.18%)
QDEL : 56.96 (-3.11%)
ABIOMED Gets FDA Confirmation of the Safety of Impella RP

ABIOMED (ABMD) receives the FDA confirmation of the safety and effectiveness of the company's Impella RP heart pump.

ABMD : 252.92 (-1.61%)
HAE : 115.88 (-0.62%)
CSII : 41.15 (-1.18%)
QDEL : 56.96 (-3.11%)
Masimo Gets FDA Nod for Radius PPG, Boosts Patient Monitoring

Masimo (MASI) receives FDA 510 (k) clearance for Radius PPG, which is set to become an important breakthrough in patient monitoring.

MASI : 142.33 (-1.43%)
HAE : 115.88 (-0.62%)
CSII : 41.15 (-1.18%)
QDEL : 56.96 (-3.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade CSII with:

Business Summary

Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360' Orbital Atherectomy System,...

See More

Key Turning Points

2nd Resistance Point 43.06
1st Resistance Point 42.35
Last Price 41.15
1st Support Level 41.18
2nd Support Level 40.72

See More

52-Week High 45.61
Last Price 41.15
Fibonacci 61.8% 37.68
Fibonacci 50% 35.23
Fibonacci 38.2% 32.78
52-Week Low 24.84

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar